5 Things We Learned This Month:
1. “Smart” nanowires could deliver drug therapy
Nanowires have been developed that can be loaded with drugs, with their release being switched “on” or “off” by the application of a strong electromagnetic field. Current range is 3 cm, but that’s deep enough for most ocular use-case scenarios…
2. Eyedrops could dissolve cataracts
Lanosterol, a molecule produced in the human body, can help to dissolve protein aggregates in the eye that contribute to cataract – and a clinical trial is set to start next year.
3. Minimally invasive corneal neurotomy matters
Corneal anesthesia is a debilitating condition caused by a lack of pain sensation in the cornea. But a sural nerve graft from the leg can restore sensation. Once major surgery, it’s now a minimally invasive procedure.
4. A protocol for stem cell section could help pick cell sources for retinal therapy
STEM-RET, a protocol to assess retinogenesis, could help standardize quantification of stem cell differentiation, and allow better selection of cells for therapeutic use.
5. There’s a unicellular organism with an eye-like structure
Warnowiid dinoflagellate, a single-celled plankton, has evolved a miniature mimic of the multicellular eye – and its structure demonstrates a striking case of convergent evolution.
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Ophthalmologist site. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.